ProPhase Labs Announces Closing of Public Offering of Common Stock
ProPhase Labs, Inc. (PRPH)
US:NASDAQ Investor Relations:
prophaselabs.com/investors/annual-reports
Company Research
Source: GlobeNewswire
GARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the closing of its previously announced underwritten public offering of 4,795,500 shares of its common stock, including 625,500 shares sold upon full exercise of the underwriter's option to purchase additional shares. Each share of common stock was sold at a public offering price of $0.72 per share, for gross proceeds of approximately $3.45 million, before deducting underwriting discounts and offering expenses. All of the shares were sold by the Company. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes, which may include capital expenditures, product development and commercialization expenditures, and acquisitions of companies, businesses, technologies and products within and outside the diagnostic services, genomics and consum
Show less
Read more
Impact Snapshot
Event Time:
PRPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRPH alerts
High impacting ProPhase Labs, Inc. news events
Weekly update
A roundup of the hottest topics
PRPH
News
- ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures [Yahoo! Finance]Yahoo! Finance
- ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting MeasuresGlobeNewswire
- ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... [Yahoo! Finance]Yahoo! Finance
- Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) [Yahoo! Finance]Yahoo! Finance
- ProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
PRPH
Earnings
- 11/13/24 - Miss
PRPH
Sec Filings
- 11/21/24 - Form EFFECT
- 11/13/24 - Form 10-Q
- 11/13/24 - Form NT
- PRPH's page on the SEC website